# Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

> **NCT02417961** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 162 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** Benralizumab

## Key facts

- **NCT ID:** NCT02417961
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-27
- **Primary completion:** 2016-03-14
- **Final completion:** 2016-03-14
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417961, "Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02417961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*